BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer

Clinical trial NCT02608229 · TERMINATED

Trial details

NCT number: NCT02608229
Sponsor: Washington University School of Medicine
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer Cancer of Pancreas Cancer of the Pancreas Pancreas Cancer

Start date: 2016-06-06
Primary completion: 2019-03-27
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.